Literature DB >> 12734411

Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Oishee Chakrabarti1, Sudhir Krishna.   

Abstract

The aetiology of cervical cancer has been primarily attributed to human papillomaviruses (HPVs). These are characterized by the persistent expression of the two oncogenes, E6 and E7. Experimental studies show that E6 and E7 genes of the high risk HPVs deregulate key cell cycle controls. Recent work has uncovered new cellular partners for these proteins that throw light on many of the pathways and processes in which these viral proteins intervene. This review focuses on the regulation of host proteins by the viral oncoproteins and consequence of such interactions on cell survival, proliferation, differentiation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734411     DOI: 10.1007/bf02970152

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  135 in total

1.  Transcriptional activation by NF-kappaB requires multiple coactivators.

Authors:  K A Sheppard; D W Rose; Z K Haque; R Kurokawa; E McInerney; S Westin; D Thanos; M G Rosenfeld; C K Glass; T Collins
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Targeting of transcriptional cofactors by the HPV E6 protein: another tale of David and Goliath.

Authors:  M J O'Connor
Journal:  Trends Microbiol       Date:  2000-02       Impact factor: 17.079

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

5.  The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions.

Authors:  B Daniel; A Rangarajan; G Mukherjee; E Vallikad; S Krishna
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

6.  Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.

Authors:  M Thomas; L Banks
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

7.  Inhibition of Bak-induced apoptosis by HPV-18 E6.

Authors:  M Thomas; L Banks
Journal:  Oncogene       Date:  1998-12-10       Impact factor: 9.867

8.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

9.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  13 in total

1.  IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes.

Authors:  Usriansyah Hadis; Graham R Leggatt; Ranjeny Thomas; Ian H Frazer; Eva M Kovacs
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

2.  Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.

Authors:  Grant A Darnell; Toni M Antalis; Barbara R Rose; Andreas Suhrbier
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Human papillomavirus DNA and oncogene alterations in colorectal tumors.

Authors:  Luis Orlando Pérez; Gisela Barbisan; Anabel Ottino; Horacio Pianzola; Carlos Daniel Golijow
Journal:  Pathol Oncol Res       Date:  2010-03-17       Impact factor: 3.201

4.  Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

Authors:  Katia Zanier; Abdellahi ould M'hamed ould Sidi; Charlotte Boulade-Ladame; Vladimir Rybin; Anne Chappelle; Andrew Atkinson; Bruno Kieffer; Gilles Travé
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

5.  Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

Authors:  Abdellahi Ould M'hamed Ould Sidi; Khaled Ould Babah; Nicole Brimer; Yves Nominé; Christophe Romier; Bruno Kieffer; Scott Vande Pol; Gilles Travé; Katia Zanier
Journal:  Protein Expr Purif       Date:  2011-07-14       Impact factor: 1.650

6.  Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Xuefeng Liu; Yuhai Dai; Dan P Hartmann; John Hanover; Richard Schlegel
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

7.  Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells.

Authors:  Mayank Singh; Neeta Singh
Journal:  Mol Cell Biochem       Date:  2009-02-04       Impact factor: 3.396

8.  Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers.

Authors:  Khadem Ghaebi Nayereh; Ghaeb Khadem
Journal:  Iran J Basic Med Sci       Date:  2012-01       Impact factor: 2.699

Review 9.  Cellular binding partners of the human papillomavirus E6 protein.

Authors:  Sandy S Tungteakkhun; Penelope J Duerksen-Hughes
Journal:  Arch Virol       Date:  2008-01-03       Impact factor: 2.574

Review 10.  Multistep model of cervical cancer: participation of miRNAs and coding genes.

Authors:  Angelica Judith Granados López; Jesús Adrián López
Journal:  Int J Mol Sci       Date:  2014-09-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.